Track topics on Twitter Track topics that are important to you
Specialty diagnostics company Precipio (NASDAQ:PRPO), today announced the launch of two additional ICEme kits using its proprietary ICE-COLD PCR liquid biopsy technology. The new RUO kits enable the detection of mutations in KRAS Exons 2 & 3, which include important predictive and prognostic biomarkers, and are available on both qPCR and Sanger molecular diagnostic platforms. As quoted … Continued
The post Precipio Launches ICE COLD-PCR Liquid Biopsy Kit for Pancreatic Cancer appeared first on Investing News Network.
Original Article: Precipio Launches ICE COLD-PCR Liquid Biopsy Kit for Pancreatic CancerNEXT ARTICLE
Polymerase Chain Reaction (PCR)
PCR (Polymerase Chain Reaction) uses the ability of DNA polymerase (enzymes that create DNA molecules by assembling nucleotides, the building blocks of DNA. These enzymes are essential to DNA replication and usually work in pairs to create two ident...
Molecular diagnostics is a technique used to analyse biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. The tec...